InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 307811

Monday, 01/08/2018 9:58:31 AM

Monday, January 08, 2018 9:58:31 AM

Post# of 346002

Dana Farber newly published PS Targeting patents



Will CEO Roger Lias find it of interest that Novartis, Dana Farber, Bayer, Dart Neuroscience ....etc all have patents based upon PS Targeting and Pergrine, now Avid Bioservices have a new set of Board of Directors which must evaluate the truth behind the PS Targeting research collaborations of dozens of non Disclosed collaborations

Have the new BODs been informed of all the information made available to the prior BODs?

Have the new BODs seen all depositions from Jeanette Bleecker (changed her name to Jeanette Bona after her sabotage of Peregrine Pharmaceuticals ) and all redacted, sealed to public ...depositions and sealed court records?

Why has CEO Roger Lias failed to go MORE public with the sale or license of PS Targeting IP / etc ? Something is being hidden it seems if he does not go MORE public and possibly, may even be trying to unload it for breadcrumbs as with what happened with Medarex.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133920086

Goldman Sachs' Letter to MEDX Board of Directors (BOD) OPENLY Acknowledges that MEDX BOD Failed to Perform Its Fiduciary Responsibilities.... "

" "We [Goldman Sachs] were not requested to solicit, and did not solicit, interest from other parties with respect to an acquisition of or other business combination with the Company."

http://melanomamissionary.blogspot.com/2009/08/is-medarex-and-bristol-meyer-squibb-in.html?m=1

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133652618

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News